<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Song Z</submitter><funding>Foundation for Innovative Research Groups of the National Natural Science Foundation of China</funding><pagination>721814</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8545986</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>High levels of free fatty acids (FFA) are closely associated with obesity and the development of cardiovascular diseases. Recently, nicotinamide adenine dinucleotide (NAD) metabolism has emerged as a potential target for several modern diseases including diabetes. Herein, we explored the underlying mechanisms of NAD metabolism associated with the risk of cardiovascular disease. Our study found that nicotinamide N-methyltransferase (NNMT) mRNA levels were significantly increased in the hearts of FFA-bound-albumin-overloaded mice and in H9C2 cells treated with palmitic acid (PA). We studied the mechanisms underlining the anti-inflammatory and anti-oxidant activities of 1-methylnicotinamide (1-MNA), a metabolite of NNMT. We found a significantly higher level of reactive oxygen species, inflam</pubmed_abstract><journal>Frontiers in cardiovascular medicine</journal><pubmed_title>1-MNA Ameliorates High Fat Diet-Induced Heart Injury by Upregulating Nrf2 Expression and Inhibiting NF-κB &lt;i>in vivo&lt;/i> and &lt;i>in vitro&lt;/i>.</pubmed_title><pmcid>PMC8545986</pmcid><funding_grant_id>81570358</funding_grant_id><funding_grant_id>81300248</funding_grant_id><pubmed_authors>Gao P</pubmed_authors><pubmed_authors>Zhong X</pubmed_authors><pubmed_authors>Ning Z</pubmed_authors><pubmed_authors>Song X</pubmed_authors><pubmed_authors>Song Z</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Sun Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>1-MNA Ameliorates High Fat Diet-Induced Heart Injury by Upregulating Nrf2 Expression and Inhibiting NF-κB &lt;i>in vivo&lt;/i> and &lt;i>in vitro&lt;/i>.</name><description>High levels of free fatty acids (FFA) are closely associated with obesity and the development of cardiovascular diseases. Recently, nicotinamide adenine dinucleotide (NAD) metabolism has emerged as a potential target for several modern diseases including diabetes. Herein, we explored the underlying mechanisms of NAD metabolism associated with the risk of cardiovascular disease. Our study found that nicotinamide N-methyltransferase (NNMT) mRNA levels were significantly increased in the hearts of FFA-bound-albumin-overloaded mice and in H9C2 cells treated with palmitic acid (PA). We studied the mechanisms underlining the anti-inflammatory and anti-oxidant activities of 1-methylnicotinamide (1-MNA), a metabolite of NNMT. We found a significantly higher level of reactive oxygen species, inflam</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-05-31T22:20:06.578Z</modification><creation>2025-05-31T22:20:06.578Z</creation></dates><accession>S-EPMC8545986</accession><cross_references><pubmed>34712707</pubmed><doi>10.3389/fcvm.2021.721814</doi></cross_references></HashMap>